Courses

Applying Novel Pharmacotherapies to Improve Outcomes in Patients with Acute Leukemia

Applying Novel Pharmacotherapies to Improve Outcomes in Patients with Acute Leukemia

Program Overview

This CME/CE activity will highlight recent data for the treatment and management of acute leukemia, including information presented at the American Society of Hematology Annual Meeting in Orlando, Florida. The expert faculty, chaired by Eytan M. Stein, MD, will first discuss the pathophysiology of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), reviewing diagnostic criteria and comorbidities ...
View Course
Advanced Strategies to Improve CVD Outcomes in Patients with Chronic Coronary Artery Disease and Peripheral Artery Disease

Advanced Strategies to Improve CVD Outcomes in Patients with Chronic Coronary Artery Disease and Peripheral Artery Disease

Program Overview

This CME/CE program, derived from content presented at the 2019 American Heart Association Scientific Sessions in Philadelphia, Pennsylvania, will highlight advanced strategies for improving cardiovascular disease (CVD) outcomes in patients with chronic coronary artery disease (CAD) and peripheral artery disease (PAD). The expert faculty, chaired by Dr. Christopher P. Cannon, will first provide an introduction and state of ...
View Course
Intensive Antiplatelet Therapy to Improve Outcomes in Patients with Acute Coronary Syndrome

Intensive Antiplatelet Therapy to Improve Outcomes in Patients with Acute Coronary Syndrome

Program Overview

This CME program will highlight recent advances in intensive antiplatelet therapy to improve outcomes in patients with acute coronary syndrome (ACS). The expert faculty, led by Dr. Christopher P. Cannon, will review platelet inhibition science as well as unmet needs in ACS. Following, recent clinical trial data, including outcomes data, will be analyzed and clinical relevance debated in ...
View Course
Scientific Updates on Antiplatelet Therapies for the Management of Patients with Acute Coronary Syndrome

Scientific Updates on Antiplatelet Therapies for the Management of Patients with Acute Coronary Syndrome

Program Overview

This continuing education activity is derived from content presented at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada. The program will highlight recent advances in antiplatelet therapeutics for acute coronary syndrome. The expert faculty will analyze current guidelines and provide insight into best approaches for developing effective patient-specific treatment plans that include the clinical ...
View Course
An In-Depth Overview of CGRP Inhibitors & Therapeutic Implementation to Improve Patient Outcomes

An In-Depth Overview of CGRP Inhibitors & Therapeutic Implementation to Improve Patient Outcomes

Program Overview

This CME activity will review recent advances in the improvement CGRP Inhibitors & Therapeutic Implementation as presented at the American Headache Society (AHS) 2019 Philadelphia, PA. The expert faculty will discuss the immunologic and pathogenic mechanisms of CGRP as well as strategies for implementation of novel CGRP inhibitors into patient-specific treatments. The faculty will also analyze safety, efficacy, ...
View Course
Clinical Updates for the Optimal Management of Patients with Inflammatory Bowel Disease

Clinical Updates for the Optimal Management of Patients with Inflammatory Bowel Disease

Program Overview

This CME activity will review recent advances in the management of patients with Inflammatory Bowel Disease (IBD) as presented at the Digestive Disease Week (DDW) 2019 in San Diego, CA. The expert faculty will discuss the science of the inflammatory cascade as well as review recent clinical trial data for IBD treatments. The faculty will also discuss strategies ...
View Course
An In-Depth Analysis of Asthma and Emerging Pharmacotherapies for Effective Patient Management

An In-Depth Analysis of Asthma and Emerging Pharmacotherapies for Effective Patient Management

Program Overview

This CME program was derived from content presented at the Eastern Pulmonary Conference 2019 Annual Meeting in Palm Beach, Florida. The expert faculty, Dr. Sidney Braman, will review the pathophysiology and disease burden of asthma to improve patient management. Next, he will delve into the subtypes of asthma and analyze clinical data of novel pharmacotherapies to determine treatment ...
View Course
Advances in the Management and Treatment of Patients with Previously-Treated Non-Small Cell Lung Cancer

Advances in the Management and Treatment of Patients with Previously-Treated Non-Small Cell Lung Cancer

Program Overview

This CME program was derived from content presented at the Eastern Pulmonary Conference 2019 Annual Meeting in Palm Beach, Florida. Drs. Charles Powell and Julie Barta will review the most recent discoveries about non-small cell lung cancer (NSCLC) tumor microenvironment as well as strategies for the treatment and management of NSCLC. The expert faculty will review strategies to ...
View Course
New Therapeutic Options for Acute and Chronic Hyperkalemia

New Therapeutic Options for Acute and Chronic Hyperkalemia

Program Overview

This CME/CE program, derived from content presented at the 2019 American Heart Association Scientific Sessions in Philadelphia, Pennsylvania, will highlight new therapeutic options for acute and chronic hyperkalemia. The expert faculty, led by Dr. Charles V. Pollack, Jr., will first provide an introduction and state of the science of hyperkalemia, including risk assessment and disease burden. Recent trial ...
View Course
Incorporating Innovative Pharmaceuticals to Achieve Optimal Outcomes in Patients with Breast Cancer

Incorporating Innovative Pharmaceuticals to Achieve Optimal Outcomes in Patients with Breast Cancer

Program Overview

This continuing education program will highlight recent advances in the treatment and management of breast cancer, with a focus on HER2-targeted therapy. The expert faculty will review the current treatment landscape for both early stage and metastatic breast cancer. Recent clinical trial data of emerged and emerging agents, particularly best practices for optimizing HER2-targeted therapy continuing into the ...
View Course
Loading...